Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale

David Gaffney, Bill Small, Henry Kitchener, Sang Young Ryu, Akila Viswanathan, Ted Trimble, Al Covens, Sarikapan Wilailak, Arb Aroon Lertkhachonsuk, Chomporn Sitathanee, Umesh Mahantshetty, Brandon Fisher, Susan Springer, Thomas Pollatz, Antonius Spiller, Monica Bacon, Anuja Jhingran

Research output: Contribution to journalArticlepeer-review

Abstract

Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.

Original languageEnglish (US)
Pages (from-to)1690-1693
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume26
Issue number9
DOIs
StatePublished - Nov 1 2016

Keywords

  • Brachytherapy
  • CCRN
  • Cervical cancer
  • Cervix cancer
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale'. Together they form a unique fingerprint.

Cite this